Innovida Savings Program

Eligible patients pay $0 copay for all Innovida generic products

Savings card

Product Details

Sumatriptan and Naproxen sodium tablet 85 mg/500 mg for oral administration contains 119 mg of sumatriptan succinate, USP equivalent to 85 mg of sumatriptan and 500 mg of naproxen sodium, USP. Each tablet also contains the inactive ingredients microcrystalline cellulose, dibasic calcium phosphate anhydrous, hypromellose, povidone, croscarmellose sodium, colloidal silicon dioxide, sodium chloride, sodium citrate, crospovidone, magnesium stearate, titanium dioxide, polyethylene glycol, FD&C Blue No. 2, FD&C Yellow No. 6, and iron oxide yellow.

Indications and Usage

Sumatriptan and naproxen sodium tablets are a combination of sumatriptan, a serotonin (5-HT) 1b/1d receptor agonist (triptan), and naproxen sodium, a non-steroidal anti-inflammatory drug, indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older.

Dosage and Administration

Sumatriptan and naproxen sodium tablet is 85 mg/500 mg. The tablets are blue, oval, biconvex, film-coated tablets, debossed with “410” on one side and plain on other side.

Information for the Patient

Please download packing insert for full prescribing information.


Please download packing insert for warnings and precautions.